Lindsey’s onboarding supports NextBeam’s growing momentum. In 2023, NextBeam achieved remarkable milestones, including the ...

Activist investor Politan immediately snubbed Masimo’s offer to accept one nominee to its board, insisting two new directors are needed to resolve governance issues at the pulse oximetry specialist.

In April, the EPA issued a final rule that would limit emissions of ethylene oxide from device sterilizers. The FDA is also taking actions to help reduce emissions of the toxic sterilant.

LEHI, UTAH – Galvan, the Silicon Slopes-based company building wellness centered blockchain-based products and services, ...

McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

A problem with Tandem’s iPhone app could drain the battery of the connected insulin pump, causing it to power down sooner than expected.

After months of safety concerns, the FDA said Getinge has yet to “sufficiently” address the problems and risks.

Officials will accept atrial fibrillation data collected by the wearable as a secondary endpoint in studies of cardiac ablation devices.

No one solution can match the scope and scale of ethylene oxide, but a “multi-pronged approach” can help reduce emissions, an FDA official said.

Evercore and Cowen analysts expect Colosense to have a limited impact on Exact Sciences’ rival Cologuard test.

Sonio’s software uses deep learning to improve image quality. Its software will remain compatible with all ultrasound machines, the company said.

Medtronic expects sales in China of the Symplicity Spyral blood pressure treatment to “be modest in the short-term.” ...